Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,056 | 704 | 99.5% |
| Education | $41.05 | 6 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,373 | 84 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $819.60 | 58 | $0 (2022) |
| Lilly USA, LLC | $786.39 | 88 | $0 (2021) |
| PFIZER INC. | $732.35 | 70 | $0 (2021) |
| Allergan, Inc. | $527.24 | 49 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $416.58 | 35 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $409.21 | 33 | $0 (2021) |
| Novo Nordisk Inc | $408.89 | 37 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $365.11 | 27 | $0 (2021) |
| AbbVie Inc. | $337.47 | 26 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.40 | 1 | Novo Nordisk Inc ($22.40) |
| 2023 | $21.86 | 1 | Novo Nordisk Inc ($21.86) |
| 2022 | $44.38 | 2 | Kowa Pharmaceuticals America, Inc. ($24.94) |
| 2021 | $1,504 | 98 | AbbVie Inc. ($284.88) |
| 2020 | $2,281 | 151 | AstraZeneca Pharmaceuticals LP ($425.85) |
| 2019 | $2,070 | 169 | AstraZeneca Pharmaceuticals LP ($447.90) |
| 2018 | $1,743 | 155 | Janssen Pharmaceuticals, Inc ($293.61) |
| 2017 | $1,411 | 133 | AstraZeneca Pharmaceuticals LP ($210.30) |
All Payment Transactions
710 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Obesity | ||||||
| 12/18/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Obesity | ||||||
| 03/15/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $24.94 | General |
| Category: Cardiovascular | ||||||
| 02/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/05/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Diabetes | ||||||
| 10/26/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY, TRIJARDY XR | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: DIABETES | ||||||
| 10/15/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Neuroscience | ||||||
| 10/12/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Neuroscience | ||||||
| 10/01/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2021 | Ironwood Pharmaceuticals, Inc | Linzess (Drug), GIVLAARI | Food and Beverage | Cash or cash equivalent | $14.34 | General |
| Category: GI | ||||||
| 08/31/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/31/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.76 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/24/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Neuroscience | ||||||
| 08/19/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Cardio-renal | ||||||
| 08/18/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Gastroenterology | ||||||
| 08/18/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: PRIMARY CARE | ||||||
| 08/12/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: UROLOGY | ||||||
| 07/27/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: WOMENS HEALTH | ||||||
| 07/26/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 23 | 1,496 | 1,934 | $140,171 | $67,331 |
| 2020 | 31 | 2,354 | 3,332 | $243,464 | $106,371 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 272 | 418 | $61,028 | $28,636 | 46.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 108 | 108 | $17,064 | $13,212 | 77.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 100 | 112 | $10,976 | $5,036 | 45.9% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 63 | 63 | $3,357 | $2,260 | 67.3% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 72 | 72 | $3,216 | $1,949 | 60.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 18 | $3,564 | $1,926 | 54.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 11 | 11 | $2,508 | $1,667 | 66.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 32 | 33 | $2,970 | $1,565 | 52.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 87 | 87 | $3,480 | $1,462 | 42.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 100 | 101 | $7,474 | $1,352 | 18.1% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 16 | 16 | $1,622 | $1,263 | 77.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 18 | 18 | $1,350 | $1,175 | 87.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 258 | 351 | $7,020 | $1,046 | 14.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 49 | 49 | $1,147 | $823.20 | 71.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 14 | 15 | $1,005 | $769.65 | 76.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 84 | 96 | $3,360 | $745.92 | 22.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 57 | 65 | $2,860 | $631.15 | 22.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 27 | 55 | $2,310 | $506.60 | 21.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 13 | 13 | $1,157 | $425.48 | 36.8% |
| 0031A | Adm sarscov2 vac ad26 .5ml | Office | 2021 | 16 | 16 | $528.00 | $403.52 | 76.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 18 | 18 | $540.00 | $274.86 | 50.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 50 | 59 | $1,475 | $185.26 | 12.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 17 | 140 | $161.00 | $16.52 | 10.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 370 | 661 | $96,506 | $40,259 | 41.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 197 | 197 | $31,126 | $21,310 | 68.5% |
About Dr. Timothy Chen, MD
Dr. Timothy Chen, MD is a Family Medicine healthcare provider based in Madison, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2010. The National Provider Identifier (NPI) number assigned to this provider is 1073830790.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Chen, MD has received a total of $9,097 in payments from pharmaceutical and medical device companies, with $22.40 received in 2024. These payments were reported across 710 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($9,056).
As a Medicare-enrolled provider, Chen has provided services to 3,850 Medicare beneficiaries, totaling 5,266 services with total Medicare billing of $173,702. Data is available for 2 years (2020–2021), covering 54 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Madison, MS
- Active Since 04/21/2010
- Last Updated 03/07/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073830790
Products in Payments
- FARXIGA (Drug) $1,127
- XARELTO (Drug) $734.39
- VRAYLAR (Drug) $442.03
- JARDIANCE (Drug) $429.12
- EMGALITY (Drug) $366.84
- XIFAXAN (Drug) $335.75
- CHANTIX (Drug) $331.36
- Livalo (Drug) $263.87
- Aimovig (Biological) $250.69
- Trintellix (Drug) $225.19
- NURTEC ODT (Drug) $216.13
- UBRELVY (Drug) $205.43
- JANUVIA (Drug) $201.54
- VYVANSE (Drug) $200.34
- MYRBETRIQ (Drug) $192.20
- AJOVY (Drug) $168.88
- TRULICITY (Drug) $159.35
- EUCRISA (Drug) $137.20
- Ozempic (Drug) $123.26
- Belviq (Drug) $122.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Madison
Gary Johnson, Md, MD
Family Medicine — Payments: $301,766
Dr. Frederick Freitag, D.o, D.O
Family Medicine — Payments: $228,855
Michael Ostrov, Md, MD
Family Medicine — Payments: $160,148
Lewis Johnston, M.d, M.D
Family Medicine — Payments: $26,320
James Bigham, Md, MD
Family Medicine — Payments: $26,208
Dr. Peter Geleskie, M.d, M.D
Family Medicine — Payments: $22,887